Canaccord Genuity analyst William Plovanic lowered the price target on Neuronetics (NASDAQ: STIM) to $3.00 (from $6.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Form DEFA14A Neuronetics, Inc. August 12, 2024 5:17 PM Form 8-K Neuronetics, Inc. For: Aug 12August 12, 2024 5:11 PM William Blair Downgrades Neuronetics (STIM) to Market PerformAugust 12, 2024 3:19 PM Form DEFA14A Neuronetics, Inc. August 12, 2024 8:34 AM Form 8-K Neuronetics, Inc. For: Aug 12August 12, 2024 8:32 AM Form 10-Q Neuronetics, Inc. For: Jun 30August 12, 2024 7:31 AM Neuronetics (STIM) and Greenbrook TMS Announce Definitive Agreement to MergeAugust 12, 2024 7:15 AM Neuronetics and Greenbrook TMS Announce Definitive Agreement to MergeAugust 12, 2024 7:15 AM Neuronetics (STIM) Misses Q2 EPS by 6c ; Offers GuidanceAugust 12, 2024 7:13 AM Neuronetics Reports Record Second Quarter 2024 Financial and Operating ResultsAugust 12, 2024 7:10 AM